Clinical trial
Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2
NCT00149162 · Assistance Publique - Hôpitaux de Paris, Other · Unknown status
Key facts
| NCT number | NCT00149162 |
|---|---|
| Title | Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2 |
| Official title | Multicenter Protocol in Treating Patients With Childhood Acute Myeloid Leukemia. Randomized Study of Maintenance Treatment With Interleukin-2 |
| Acronym | Elam02 |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | Chiron Corporation Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | proleukin |
| Enrollment | 580 |
| Start date | Mar 1, 2005 |
| Primary completion | Dec 1, 2010 |
| Completion | Mar 1, 2012 |
| First posted | Sep 8, 2005 |
| Last update posted | Feb 12, 2009 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: